CN102994409B - New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof - Google Patents
New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof Download PDFInfo
- Publication number
- CN102994409B CN102994409B CN201210260349.XA CN201210260349A CN102994409B CN 102994409 B CN102994409 B CN 102994409B CN 201210260349 A CN201210260349 A CN 201210260349A CN 102994409 B CN102994409 B CN 102994409B
- Authority
- CN
- China
- Prior art keywords
- penneri
- ubiquinone
- application
- bacterial strain
- coenzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides a new bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications of the proteus penneri CA8 in preparation of the coenzyme Q10 by microbial fermentation. The bacterial strain is preserved in China Center for Type Culture Collection, the address is 430072, Wuhan University, Wuhan, China, the preservation number is CCTCC No: M2012208, and the preservation date is June 10, 2012. The new bacterial strain-proteus penneri CA8 for generating the coenzyme Q10 has the following main beneficial effects: the new coenzyme Q10 producing strain is provided, and the coenzyme Q10 is prepared by utilizing the microbial fermentation of the strain, so that yield is high, the subsequent extraction method is simple, and the industrial production is facilitated.
Description
(1) technical field
The present invention relates to a strain and produce ubiquinone
10new bacterial strain---P.penneri CA8 and prepare ubiquinone in microorganism fermentation
10in application, belong to microbiological pharmacy field.
(2) background technology
Ubiquinone
10(CoenzymeQ
10, CoQ
10) be extensively present in animal, plant and microbe, be hydrogen carrier important in biomass cells respiratory chain, be also a kind of good biochemical drug.It has oxidation-resistance, eliminates free radical, improves the functions such as immunity of organisms, has been widely used in the treatment of the diseases such as all kinds of heart troubles, diabetes, cancer, acute, chronic hepatitis, parkinsonism.Prepare ubiquinone
10method mainly contain zooblast extraction method, tobacco leaf Salanesol semi-synthesis method, synthesis method, microbe fermentation method or culture plant cell method completely.Compare with additive method, microbe fermentation method has that its lytic activity is high, raw materials cost is low, easy to control and can realize the features such as scale operation.Obtaining good fermentation strain is Production by Microorganism Fermentation ubiquinone
10one of key.The ubiquinone of having reported at present
10fermentation strain mainly belongs to Pseudomonas, Saccharomycodes, photosynthetic bacterium genus and paracoccus etc.Fermentation thalline extracts ubiquinone
10method mostly is alcohol alkali soap method for post extraction, and step is loaded down with trivial details, waste time and energy, and it is larger to extract solvent loss.
(3) summary of the invention
The object of the invention is in order to provide a strain to produce ubiquinone
10output is new bacterial strain preferably, and utilizes this strain fermentating liquid to prepare ubiquinone
10method.
The technical solution used in the present invention is:
One strain ubiquinone
10bacterium---P.penneri (Proteus penneri) CA8, is preserved in Chinese Typical Representative culture collection center, address: China in generation, Wuhan, Wuhan University, 430072, deposit number: CCTCC No:M 2012208, preservation date: on June 10th, 2012.
Described P.penneri CA8 feature is as follows: bacterial strain on LB agar plate, cultivate after 1 day, be translucent moist, less, circle, smooth surface, easily provokes; It is shaft-like that thalline is, and size is (0.4~1.0) μ m * (0.8~1.8) μ m, and tool whole body flagellum, can move, and Gram-negative, without gemma; Amphimicrobian, phenylalanine test is positive, and oxydase reaction, gelatin hydrolysis test, indole test, IMViC test, V-P reaction are negative, and utilize glucose, lactose etc. to produce acid, and unfavorable with saligenin, optimum growth temperature is 37 ℃.
CA8 bacterial strain of the present invention, separated from the Ebolowa of Cameroon soil, through the Phylogenetic Analysis of morphology, Physiology and biochemistry, Biolog GEN Ш evaluation and 16S rRNA sequence, find that this bacterial strain belongs to P.penneri, called after Proteus penneri CA8.There is not yet at present relevant Bacillus proteus is both at home and abroad applied at ubiquinone
10the research report of producing.
The present invention ferment thalline ultrasonication and extract ubiquinone
10technique have no equally report.
The invention still further relates to described P.penneri CA8 and prepare ubiquinone in microorganism fermentation
10in application.
Described being applied as: with P.penneri CA8, be inoculated in the liquid nutrient medium that is applicable to P.penneri, at 30 ~ 37 ℃, cultivate 48 ~ 60 h, the centrifugal collection wet thallus of gained fermented liquid, wet thallus extracts and obtains described ubiquinone through fragmentation
10.
The described liquid nutrient medium that is applicable to P.penneri is the conventional liquid nutrient medium that is applicable to P.penneri, can prepare by following composition: carbon source 10 ~ 20 g, nitrogenous source 5 ~ 15 g, KH in the present invention
2pO
40.5 g, Na
2hPO
41.5 g, MgSO
40.5 g, water 1000 ml, pH6.0 ~ 8.0.
Described carbon source is the conventional carbon source for substratum preparation, as glucose, sucrose, maltose, lactose etc., is preferably lactose.
Described nitrogenous source is the conventional carbon source for substratum preparation, as yeast extract paste, ammonium sulfate etc., is preferably yeast extract paste.
More preferred, described in be applicable to P.penneri liquid nutrient medium by following composition, prepare: add lactose 40 g, yeast extract paste 40 g, KH
2pO
40.5 g, Na
2hPO
41.5 g, MgSO
40.5 g, water 1000 ml, pH8.0.
Preferably, described fragmentation is extracted as ultrasonication and extracts, and method is as follows: wet thallus is moved in centrifuge tube, add enough ethanol, mix, and after 300 ~ 500 W supersound process 8 ~ 10 min, centrifugal, filter, in filtrate, obtain described ubiquinone
10.
Beneficial effect of the present invention is mainly reflected in: provide a strain new ubiquinone
10produce bacterium, utilize this strain microorganism fermentation to prepare ubiquinone
10, output is high, and subsequent extracted method is simple, is beneficial to suitability for industrialized production.
(4) accompanying drawing explanation
Fig. 1 is the Electronic Speculum figure (* 30000) of P.penneri (Proteus penneri) CA8;
Fig. 2 is that different carbon sources are to CA8 ubiquinone
10the impact of output;
Fig. 3 is that different nitrogen sources is to CA8 ubiquinone
10the impact of output;
Fig. 4 is that lactose concn is to CA8 ubiquinone
10the impact of output;
Fig. 5 is that yeast extract paste concentration is to CA8 ubiquinone
10the impact of output;
Fig. 6 is that temperature is to ubiquinone
10the impact of output;
Fig. 7 is that liquid amount is to ubiquinone
10the impact of output;
Fig. 8 is that initial pH value is to ubiquinone
10the impact of output.
(5) embodiment
Below in conjunction with specific embodiment, the present invention is described further, but protection scope of the present invention is not limited in this:
Embodiment: ubiquinone is produced in the separation of P.penneri (Proteus penneri) CA8, evaluation and fermentation thereof
10characteristic
1, the separation of bacterial strain:
(1) collected specimens
Gather after the Ebolowa of Cameroon pedotheque, get 10 g, add sterilized water 90 ml, make Soil Slurry.Draw supernatant liquor and make 10 with sterilized water dilution
-1, 10
-2, 10
-3, 10
-4, 10
-5, 10
-6different extent of dilution.
(2) strains separation
Get bacteria suspension 1 ml, in the flat lining out of selectivity, selective medium was prepared by following composition: isoprene 0.5 ml, (NH
4)
2sO
41.0 g, KH
2pO
44.5 g, Na
2hPO
412H
2o 21.6 g, agar 15~20 g, water 1000 ml, pH 7.0.
According to the ordinary method of microorganism Pure strain separation, above-mentioned separation and Culture is placed to 2~3 d based on 28 ℃.A plurality of single bacterium colonies of picking, are inoculated on slant medium, and numbering is preserved.In liquid medium within, carry out fermentable check, result obtains a strain ubiquinone again
10the bacterial strain CA8 that output is higher.Substratum used was prepared by following composition: glucose 20 g, peptone 10 g, yeast extract paste 10 g, KH
2pO
40.5 g, Na
2hPO
41.5 g, MgSO
47H
2o 0.5 g, water 1000 ml, pH7.0.(as being solid medium, adding again the agar of 20 g/L).
2, the evaluation of bacterial strain
(1) ubiquinone
10produce thalline and the colony morphology characteristic of bacterium CA8
Ubiquinone
10it is shaft-like producing bacterium CA8, and size is (0.4~1.0) μ m * (0.8~1.8) μ m, Gram-negative, and without gemma, tool whole body flagellum, can move; Bacterium colony is translucent moist, less, circle, and smooth surface, easily provokes.
(2) ubiquinone
10produce the physiological and biochemical property of bacterium CA8
Physiological and biochemical property is: amphimicrobian, and phenylalanine test is positive, and oxydase reaction, gelatin hydrolysis test, indole test, IMViC test, V-P reaction are negative, and utilize glucose, lactose etc. to produce acid, the unfavorable saligenin of using.
The Physiological-biochemical Characters of the P.penneri that above-mentioned mycology feature and document (uncle Jie Shi Bacteria Identification handbook) are edited and recorded matches.In conjunction with 16S rRNA sequence homology analysis and the Biolog systems analysis result of bacterial strain, this bacterium pearl is accredited as the product ubiquinone that belongs to P.penneri
10new bacterium pearl.
3, produce ubiquinone
10performance
P.penneri (Proteus penneri) CA8, with 5 % inoculum sizes, is inoculated in to 500 ml 100 ml liquid nutrient mediums (20 g carbon sources, 10 g peptones, 10 g yeast extract pastes, KH are housed
2pO
40.5 g, Na
2hPO
41.5 g, MgSO
40.5 g, water complements to 1000 ml, pH 7.0) shaking flask in, using these several conventional carbon sources of glucose, sucrose, maltose and lactose as the carbon source of fermentation, investigate its cell growth total amount and ubiquinone
10the impact of total amount, carries out single factor research of carbon source.
Result as shown in Figure 2, shows that the utilization of carbon source is to bacteria growing amount and ubiquinone
10yield effect is more inhomogeneous.From bacteria growing amount and ubiquinone
10proportionlity between output, lactose is optimum carbon source.
Carry out on this basis the impact research of lactose concn interpolation, result as shown in Figure 4, ubiquinone when Inclusion of Lactose is 40 g/L
10output is higher.
P.penneri (Proteus penneri) CA8, with 5 % inoculum sizes, is inoculated in to liquid nutrient medium (40 g lactose, 10 g nitrogenous sources, KH
2pO
40.5 g, Na
2hPO
41.5 g, MgSO
40.5 g, water complements to 1000 ml, pH 7.0), as shown in Figure 3, result shows the result of nitrogenous source: in organic nitrogen source, take yeast extract paste as best, itself and inorganic nitrogen-sourced ammonium sulfate comparison, the inorganic nitrogen-sourced thalli growth that is unfavorable for.Carry out on this basis the impact research of yeast extract paste concentration interpolation, as shown in Figure 5, result shows result: ubiquinone when yeast extract paste addition is 40 g/L
10output is higher.
Investigate respectively differing temps, liquid amount, initial pH value cell growth total amount and ubiquinone
10the impact of total amount.Result, as shown in Fig. 6, Fig. 7, Fig. 8, shows when temperature, liquid amount, initial pH are divided into 30 ℃, 80 ml, fermentation preparation of cozymase Q 8.0 time
10best.
With this understanding, by bacterial strain P.penneri (Proteus penneri) CA8 fermentation, produce ubiquinone
10output the highest, reached 105.1 mg/L, than before optimizing, improved 500%.
Claims (8)
1. a strain ubiquinone
10bacterium---P.penneri (Proteus penneri) CA8, is preserved in Chinese Typical Representative culture collection center, address: China in generation, Wuhan, Wuhan University, 430072, deposit number: CCTCC No:M2012208, preservation date: on June 10th, 2012.
2. P.penneri CA8 as claimed in claim 1 prepares ubiquinone in microorganism fermentation
10in application.
3. application as claimed in claim 2, described in it is characterized in that, be applied as: with P.penneri CA8, be inoculated in the liquid nutrient medium that is applicable to P.penneri, at 30~37 ℃, cultivate 48~60h, the centrifugal collection wet thallus of gained fermented liquid, wet thallus extracts and obtains described ubiquinone through fragmentation
10.
4. application as claimed in claim 3, the liquid nutrient medium that is applicable to P.penneri described in it is characterized in that is prepared by following composition: carbon source 10~20g, nitrogenous source 5~15g, KH
2pO
40.5g, Na
2hPO
41.5g, MgSO
40.5g, water 1000ml, pH6.0~8.0.
5. application as claimed in claim 4, is characterized in that described carbon source is lactose.
6. application as claimed in claim 4, is characterized in that described nitrogenous source is yeast extract paste.
7. application as claimed in claim 3, the liquid nutrient medium that is applicable to P.penneri described in it is characterized in that is prepared by following composition: add lactose 40g, yeast extract paste 40g, KH
2pO
40.5g, Na
2hPO
41.5g, MgSO
40.5g, water 1000ml, pH8.0.
8. application as claimed in claim 3, is characterized in that described fragmentation is extracted as ultrasonication and extracts, and method is as follows: wet thallus is moved in centrifuge tube, add enough ethanol, mix, after 300~500W supersound process, 8~10min, centrifugal, filter, in filtrate, obtain described ubiquinone
10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210260349.XA CN102994409B (en) | 2012-07-20 | 2012-07-20 | New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210260349.XA CN102994409B (en) | 2012-07-20 | 2012-07-20 | New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102994409A CN102994409A (en) | 2013-03-27 |
CN102994409B true CN102994409B (en) | 2014-09-03 |
Family
ID=47923522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210260349.XA Active CN102994409B (en) | 2012-07-20 | 2012-07-20 | New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102994409B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3066080A (en) * | 1961-03-22 | 1962-11-27 | Merck & Co Inc | Fermentation production of coenzyme q-10 |
US3658648A (en) * | 1966-09-17 | 1972-04-25 | Takeda Chemical Industries Ltd | Method for the production of coenzyme q |
CN101654664A (en) * | 2009-09-25 | 2010-02-24 | 厦门百拓生物工程有限公司 | Fermentation production method and application of high-yield exopolysaccharide strain and amylase thereof |
-
2012
- 2012-07-20 CN CN201210260349.XA patent/CN102994409B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3066080A (en) * | 1961-03-22 | 1962-11-27 | Merck & Co Inc | Fermentation production of coenzyme q-10 |
US3658648A (en) * | 1966-09-17 | 1972-04-25 | Takeda Chemical Industries Ltd | Method for the production of coenzyme q |
CN101654664A (en) * | 2009-09-25 | 2010-02-24 | 厦门百拓生物工程有限公司 | Fermentation production method and application of high-yield exopolysaccharide strain and amylase thereof |
Non-Patent Citations (1)
Title |
---|
Coenzyme Q. XVII. Isolation of Coenzyme Q10 from Bacterial Fermentation;A.C.PAGE,JR.等;《ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS》;19601231;第89卷;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN102994409A (en) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102888351B (en) | Prodigiosin high-producing strain and production method thereof | |
CN106554931B (en) | Carboxylic acid bacterium bailii and application thereof | |
CN104342390A (en) | Sinorhizobium meliloti strain and composition and application of sinorhizobium meliloti strain | |
CN102337312A (en) | Method for increasing yield of chondroitin sulfate produced by fermentation method | |
CN102586151B (en) | High-yield polysaccharide strain and method for producing polysaccharide by utilizing strain through fermentation | |
Ramprakash et al. | Biohydrogen production from rice mill wastewater using mutated Enterobacter aerogenes | |
CN105017086A (en) | Separation and purification method for L-citrulline | |
CN103571772A (en) | Novel strain for producing butanol and method for producing butanol | |
CN103421714A (en) | Bacillus shackletonii and application thereof in fermentation production of polyhydroxybutyrate | |
CN104630166A (en) | Method for producing low-temperature glucose oxidase by virtue of microbial fermentation | |
CN103276019A (en) | Method for promoting lycopene synthesis in blakeslea trispora | |
CN104673712A (en) | Bacterial strain for producing alcohol fuels by synchronously utilizing glucose and xylose and application of bacterial strain | |
CN104630167A (en) | Method for producing low-temperature glucose oxidase by fermentation of marine microorganisms | |
CN102676406B (en) | Candida tropicalis used for fermenting and producing ribonucleic acid and application thereof | |
CN105176859A (en) | Strain MQO-153 for production of arginine deiminase | |
CN106995789B (en) | Resveratrol zymocyte and application thereof | |
CN107937307A (en) | One plant of bacteria cellulose Producing Strain and its optimal fermentation condition | |
CN116200286B (en) | Clostridium thermocellum capable of efficiently saccharifying cellulose and application thereof | |
CN108384730B (en) | Lactobacillus paracasei and application thereof in conversion synthesis of phenyllactic acid | |
CN103468606B (en) | Klebsiella oxytoca and application thereof in allitol production | |
CN114015607B (en) | Bacillus amyloliquefaciens for high yield of 5-methyltetrahydrofolic acid and application thereof | |
CN103146595A (en) | Bacillus subtilis and method for fermentation production of D- ribose | |
CN102994409B (en) | New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof | |
CN105177075A (en) | Method for preparation of L-citrulline with arginine as raw material | |
CN101177670B (en) | Novel strain sphingosine gingivalis ZUTE03 for producing coenzyme Q10 and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181031 Address after: 322000 No. 269 embroidery Road West, Beiyuan street, Yiwu, Jinhua, Zhejiang. Patentee after: Zhejiang Zhongke long life medical science and Technology Co Ltd Address before: 310014 Chao Wang Road, Xiacheng City, Hangzhou, Zhejiang Province, No. 18 Patentee before: Zhejiang University of Technology |